Home/NuCana/Theresa Bruce
TB

Theresa Bruce

Chief Operating Officer

NuCana

Therapeutic Areas

NuCana Pipeline

DrugIndicationPhase
NUC-3373Colorectal Cancer, Biliary Tract CancerPhase 2
NUC-7738PD-1 Resistant Melanoma, Advanced Solid TumorsPhase 2
NUC-8232Various Solid TumorsPhase 1